Link roundup, things you might like

the future of the book is ….

The future of the book, the printed book, is up in the air. People stand to make a lot of money if they can convince you that their version of the future of print and reading is correct. Many of us would just like to separate the wheat from the chaff and keep delivering good content to various sorts of readers, from now until forever. The Green Mountain Library Consortium released their statement about Harper Collins this week which, while not as strong as I personally would have liked, I think sends a “hey man, not cool” message and at least sends a “hey we’re paying attention” message which I think is the important part. In the meantime, there are a lot of people who have a fairly good understanding of the general ebook situation who are deciding to poke a bit of fun at the crazy world we’re currently inhabiting. John Scalzi has made an electronic publishing bingo card which, while amusing in and of itself, has a weath of great discussion in the comments.

I’ll note that I spent a good chunk of time over this past week going over my page proofs [again] and yet I have no idea at all what the ebook for my book will look like or even what format(s) it will be available in. I can’t wait for this in-between time to be over with.

Real Lives Revealed – readers advisory by Rick Roche

Longtime friend of librarian.net ricklibrarian [aka Rick Roche] has published a book Real Lives Revealed A Guide to Reading Interests in Biography featuring 600 revieed and categorized biographies. Nice job Rick. For those of you going to ALA, be sure to say howdy and check the book out.

in case you needed another reason to raise an eyebrow at Elsevier

I sometimes get a case of schadenfreude reading about bad things that happen to big companies that have a hand in library businesses. This latest mess involves Elsevier publishing what can charitably called a “sponsored journal” and what can uncharitably be called a fake scam journal, sponsored by Merck and internded solely to be cited in support of their drug Fosamax. If anyone has ongoing dealings with Elsevier and would like to get across to them how uncool this is, I’d appreciate it. Original article published at TheScientist.com available here with free registration. [nowthis]

Elsevier acknowledged that Merck had sponsored the publication, but did not disclose the amount the drug company paid. In a statement emailed to The Scientist, Elsevier said that the company “does not today consider a compilation of reprinted articles a ‘Journal’.”

“Elsevier acknowledges the concern that the journals in question didn’t have the appropriate disclosures,” the statement continued. “It is worth noting that project in question was produced 6 years ago and disclosure protocols have evolved since 2003. Elsevier’s current disclosure policies meet the rigor and requirements of the current publishing environment.”

The Elsevier spokesperson said the company wasn’t aware of how many copies of the Australasian Journal of Bone and Joint Medicine were produced or how the publication was distributed in Australia, but noted that “the common practice for sponsored journals is that doctors receive them complimentary.” The spokesperson added that Elsevier had no plans to look further into the matter.